Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib

被引：10

作者：

Murray, Matthew ^{[1
]}

Hatcher, Helen ^{[1
,4
]}

Jessop, Flora ^{[2
]}

Williams, Denise ^{[1
]}

Carroll, Nicholas ^{[3
]}

Bulusu, Ramesh ^{[1
]}

Judson, Ian ^{[4
]}

机构：

[1] Addenbrookes Hosp, Dept Oncol, Cambridge, England

[2] Addenbrookes Hosp, Dept Histopathol, Cambridge, England

[3] Addenbrookes Hosp, Dept Radiol, Cambridge, England

[4] Royal Marsden Hosp, Sarcoma Unit, London SW3 6JJ, England

来源：

PEDIATRIC BLOOD & CANCER | 2008年 / 50卷 / 02期

关键词：

gastrointestinal stromal tumors; imatinib; sunitinib; KIT; PDGFRA; pediatric;

D O I：

10.1002/pbc.21312

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report a rare case of advanced, metastatic gastrointestinal stromal tumor (GIST) in a young female. Molecular analysis of the tumor revealed wild-type (WT) KIT and platelet derived growth factor receptor alpha (PDGFRA) gene status with no mutations characteristic of adult GIST. Despite this she had clinical benefit and evidence of radiological response to sequential treatment with the tyrosine kinase inhibitors imatinib and sunitinib. Pediatr Blood Cancer 2008;50:386-388. (c) 2007 Wiley-Liss, Inc.

引用

页码：386 / 388

页数：3

共 50 条

[31] Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
Wasif, Komal
Wasif, Nawal
Saif, Muhammad W.
CUREUS, 2016, 8 (10):
[32] RESPONSE OF A PEDIATRIC cKIT GASTROINTESTINAL STROMAL CELL TUMOR (GIST) TO IMATINIB
Lowenstein, Sarah
Ganapathi, Shireen
Reed, Robyn
Albert, Catherine
PEDIATRIC BLOOD & CANCER, 2022, 69
[33] Imatinib Escalation or Sunitinib Treatment After First-line Imatinib in Metastatic Gastrointestinal Stromal Tumor Patients
Hsu, Chih-Chieh
Wu, Chiao-En
Chen, Jen-Shi
Tseng, Jeng-Hwei
Chiang, Kun-Chun
Liu, Yu-Yin
Tsai, Chun-Yi
Cheng, Chi-Tung
Chen, Tsung-Wen
Jan, Yi-Yin
Yeh, Ta-Sen
Chen, Yen-Yang
Yeh, Chun-Nan
ANTICANCER RESEARCH, 2014, 34 (09) : 5029 - 5036
[34] Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment
Yeh, Chun-Nan
Chen, Tsung-Wen
Liu, Feng-Yuan
Jan, Yi-Yin
Chen, Miin-Fu
LANGENBECKS ARCHIVES OF SURGERY, 2006, 391 (06) : 615 - 621
[35] Surgical Management in Metastatic Gastrointestinal Stromal Tumor (GIST) Patients After Imatinib Mesylate Treatment
Yeh, Chun-Nan
Chen, Tsung-Wen
Tseng, Jeng-Hwei
Liu, Yu-Yin
Wang, Shang-Yu
Tsai, Chun-Yi
Chiang, Kun-Chun
Hwang, Tsann-Long
Jan, Yi-Yin
Chen, Miin-Fu
JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (06) : 599 - 603
[36] Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment
Chun-Nan Yeh
Tsung-Wen Chen
Feng-Yuan Liu
Yi-Yin Jan
Miin-Fu Chen
Langenbeck's Archives of Surgery, 2006, 391 : 615 - 621
[37] Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment
Deshaies, Isabelle
Cherenfant, Jovenel
Gusani, Niraj J.
Jiang, Yixing
Harvey, Harold A.
Kimchi, Eric T.
Kaifi, Jussuf T.
Staveley-O'Carroll, Kevin F.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 453 - 458
[38] Approach to wild-type gastrointestinal stromal tumors
Kays, Joshua K.
Sohn, Jeffrey D.
Kim, Bradford J.
Goze, Katherine
Koniaris, Leonidas G.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
[39] Imatinib in gastrointestinal stromal tumour (GIST) therapy
Balana Quintero, Carmen
Cubedo, Ricardo
ANTI-CANCER DRUGS, 2012, 23 : S1 - S2
[40] COST-EFFECTIVENESS OF SUNITINIB AS SECOND-LINE TREATMENT FOR GASTROINTESTINAL STROMAL TUMOR(GIST) IN CHINA
Ren, H.
Zhang, J.
Dong, P.
VALUE IN HEALTH, 2015, 18 (07) : A455 - A455

← 1 2 3 4 5 →